AstraZeneca PLC

Bullish Two Hundred Day Moving Average Cross - AZN

04 Jan 2024 11:38:29 By NASDAQ Stocks

Bullish Two Hundred Day Moving Average Cross - AZN

04 Jan 2024 11:34:42 By NASDAQ US Markets

Allorion Therapeutic Inks Agreement With AstraZeneca For EGFR L858R Allosteric Inhibitor Program

02 Jan 2024 09:45:15 By NASDAQ US Markets

AstraZeneca To Buy Gracell For Up To $1.2 Bln

26 Dec 2023 03:23:07 By NASDAQ US Markets

AZN :FDA Oks Wainua For Treatment Of Polyneuropathy Of Hereditary Transthyretin-Mediated Amyloidosis

21 Dec 2023 20:47:36 By NASDAQ US Markets

AstraZeneca sheds £15 billion of market cap as weight-loss-pill data underwhelms investors

21 Dec 2023 20:44:53 By MarketWatch

AstraZeneca Will Acquire RSV Vaccine Developer Icosavax For $1.1 Billion

12 Dec 2023 04:30:35 By Forbes - World

AstraZeneca To Buy US-based Icosavax In Around $1.1 Bln Deal

12 Dec 2023 03:42:28 By NASDAQ US Markets

AstraZeneca : Phase III Trial Data Show Danicopan Sustained Clinical Improvements In PNH

10 Dec 2023 23:22:28 By NASDAQ US Markets

AstraZeneca Just Joined the AI Drug Development Craze, but Is It a Buy in 2024?

10 Dec 2023 09:09:34 By NASDAQ US Markets

Is Now the Right Time to Buy AstraZeneca Stock?

10 Dec 2023 07:46:15 By NASDAQ US Markets

Absci (ABSI) Up on AstraZeneca Deal to Design New Cancer Therapy

05 Dec 2023 09:27:21 By NASDAQ Stocks

Absci, AstraZeneca Join To Deliver AI-designed Antibody Against Oncology Target

04 Dec 2023 08:12:31 By NASDAQ US Markets

AstraZeneca To Discontine STABILIZE-CKD, DIALIZE-Outcomes Trials Under CRYSTALIZE Programme

01 Dec 2023 02:39:09 By NASDAQ US Markets

AstraZeneca Launches Evinova Healthtech Business

20 Nov 2023 09:21:15 By NASDAQ US Markets

Pharma Stock Roundup: FDA Okays AZN's Capivasertib & MRK's Keytruda Expanded Use

17 Nov 2023 09:20:24 By NASDAQ Stocks

AstraZeneca: Truqap Plus Faslodex Approved In US For HR+ Breast Cancer

17 Nov 2023 03:04:07 By NASDAQ US Markets

Interesting AZN Put And Call Options For July 2024

16 Nov 2023 11:57:01 By NASDAQ Stocks

AstraZeneca : Phase III Trial Of Imfinzi + Chemoradiotherapy In Lung Cancer Fails To Meet Main Goal

14 Nov 2023 03:55:47 By NASDAQ US Markets

AstraZeneca (AZN) Beats on Q3 Earnings & Sales, Ups 2023 View

10 Nov 2023 09:14:44 By NASDAQ Stocks